Announcements Trials
Browse Landscape

Phase

Phase 3 5

Status

Completed 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 5OTHER 2NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5

Conditions

Rhabdomyosarcoma 5Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Wilms Tumor 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Burkitt Lymphoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Endometrial Clear Cell Adenocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1

Interventions

Radiotherapy 9Vincristine 8Dactinomycin 8Cyclophosphamide 8Ifosfamide 6Radiation 5Filgrastim 5Doxorubicin 5Irinotecan 4sargramostim 3pegfilgrastim 2brostallicin 2Vinorelbine 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2Biopsy 2trioctyl phosphine oxide 1perifosine 1lorvotuzumab mertansine 1irinotecan sucrosofate 1imetelstat 1exatecan 1etoposide phosphate 1X-Rays 1Trabectedin 1Topotecan 1Surgical Procedures, Operative 1Spinal Puncture 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma × Radiation × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT07466316 2026-03-12

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Children's Oncology Group

Phase 3 Not yet recruiting
342 enrolled
Sarcoma

Rhabdomyosarcoma

NCT00354835 2023-01-31

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
481 enrolled 21 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma

NCT00075582 2021-11-19

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
390 enrolled 14 charts
Sarcoma

Rhabdomyosarcoma

NCT00003958 2013-06-17

Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
702 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡